Curcumin nanoemulsion for transdermal application: Formulation and evaluation

Drug Development and Industrial Pharmacy

Volumn 41, Issue 4, 2015, Pages 560-566

  Rachmawati, Heni ^a   Budiputra, Dewa Ken ^a   Mauludin, Rachmat ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

Author keywords

Curcumin; Higuchi release profile; Self assembly nanoemulsion; Shed snake skin; Transdermal

Indexed keywords

CREMOPHOR; CURCUMIN; GLYCEROL OLEATE; MACROGOL 400; ACYLGLYCEROL; DRUG CARRIER; EMULSION; EXCIPIENT; MACROGOL DERIVATIVE; NANOMATERIAL; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHASE SEPARATION; PYTHON RETICULATUS; RAMAN SPECTROMETRY; SKIN PERMEABILITY; SNAKE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BIOLOGICAL MODEL; BOIDAE; CHEMISTRY; DRUG STABILITY; EMULSION; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; SKIN; SKIN ABSORPTION; SURFACE PROPERTY; ULTRASTRUCTURE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BOIDAE; CURCUMIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; DRUG STABILITY; EMULSIONS; EXCIPIENTS; GLYCERIDES; MODELS, BIOLOGICAL; NANOSTRUCTURES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SKIN; SKIN ABSORPTION; SURFACE PROPERTIES;

EID: 84929075615     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.884127     Document Type: Article

References (25)

1. Kohli K, Ali J, Ansari MJ, Raheman Z. Curcumin: a natural antiinflammatory agent. Indian J Pharmacol 2005;37:141-7
2. Anand P, Thomas SG, Kunnumakkara AB, et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol 2008;76:1590-611
3. Jurenka JS. Anti-infammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 2009;14:141-53
4. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23: 363-98
5. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999;27:486-94
6. Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012;17:71-80
7. Delmas T, Piraux H, Couffin AC, et al. How to prepare and stabilize very small nanoemulsion. Langmuir 2011;27:1683-92
8. Wang X, Jiang Y, Wang YW, et al. Enhancing anti-inflammation activity of curcumin through o/w nanoemulsion. Food Chem 2008; 108:419-24
9. Sharma S, Parwa S, Jain UK. Development and evaluation of topical gel of curcumin from different combination of polymers formulation & evaluation of herbal gel. Int J Pharm Pharm Sci 2012;4:452-6
10. Rachmawati H, Edityaningrum CA, Mauludin R. Molecular inclusion complex of curcumin-b-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel. AAPS PharmSciTech 2013;14:1303-12
11. Tay SLM, Heng PWS, Chan LW. An investigation of the chick chorioallantoic membrane as an alternative model to various biological tissues for permeation studies. J Pharm Pharmacol 2011;63:1283-9
12. Haigh JM, Beyssac E, Chanet L, Aiache JM. In vitro permeation of progesterone from a gel through the shed skin of three different snake species. Int J Pharm 1998;170:151-6
13. Chien YW. Novel drug delivery systems. 2nd ed. London: Marcel Dekker; 1992
14. Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm 2008;355:19-30
15. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipient. 6th ed. London: Pharmaceutical Press and American Pharmacist Association; 2009
16. Zhang L, Zhu W, Yang C, et al. A novel folate-modified selfmicroemulsfying drug delivery system of curcumin for colon targeting. Int J Nanomed 2012;7:151-62
17. Mohan PRK, Sreelakshmi G, Muraleedharan CV, Joseph R. Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vib Spectros 2012;62:77-84
18. Park HJ, Kong M. Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr Polym 2011;83:1303-10
19. Harwansh RK, Patra KC, Pareta SK, et al. Nanoemulsion as vehicles for transdermal delivery of glycyrrhizin. Brazilian J Pharm Sci 2011; 47:769-78
20. Paudel KS, Milewski M, Swadley CL, et al. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 2010;1: 109-31
21. Azeem A, Ahmad FJ, Khar RK, Talegaonkar S. Nanocarrier for the transdermal delivery of antiparkinsonian drug. AAPS PharmSciTech 2009;10:1093-103
22. Ledet G, Pamujula S, Walker V, et al. Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/ 03639045.2012.763137
23. Hussain A, Samad A, Nazish I, Ahmed FJ. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045. 2013.771647
24. Dash S, Murthy PN, Nath L. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217-23
25. Verma PRP, Chandak AR. Development of matrix controlled transdermal delivery systems of pentazocine: in vitro/in vivo perfomance. Acta Pharm 2009;59:171-86.